Pfizer sought FDA approval for COVID-19 products, while Albert Bourla became CEO and successfully led the company through various stages, including acquisitions.
2 reports, 2 independent
Updated Jun 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer sought FDA approval for COVID-19 products, while Albert Bourla became CEO and successfully led the company through various stages, including acquisitions.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer CFO Dave Denton is leaving the company.Sub-event
Pfizer sought FDA approval for COVID-19 products.1 source
Pfizer leadership remains optimistic about future growth.1 source